Skip to main content

Table 2 Genotypic association of the Pro12Ala polymorphism with NAFLD

From: The Pro12Ala polymorphism in the PPAR­γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus

Variable

Genotype

OR (95% CI)

P-value

CC N (%)

GG  (%)

NAFLD patients

87 (60%)

58 (40%)

1.92 (0.742–1.917)

0.468

Control subjects

93 (64.1%)

52 (35.9%)

 

Alleles

OR (95% CI)

P-value

C N (%)

G N (%)

NAFLD patients

174 (80%)

116 (20%)

1.192 (0.852–1.668)

0.304

Control subjects

186 (82%)

104 (18%)